Glax Labs
A contract manufacturer betting that boring is beautiful.
PUBLISHED 8 JUN 2026
- Ticker
- GLAXLAB
- Exchange
- NSE
- Sector
- Pharma
- Market Cap
- ₹3,400 Cr
The founding
Built around regulatory discipline rather than blockbuster molecules.
The model
Contract manufacturing for regulated markets — high barriers, sticky customers.
The risk
Customer concentration and FDA inspections are the two things to watch.
Share:Share on LinkedIn
Get the next story in your inbox
One quality company story a week. Free, forever.
NO SPAM · UNSUBSCRIBE ANYTIME